2511.HK · HIGHTIDE-B
Hong Kong · RS rating 63 · As of 2026-10-14
| Price | 3.09 HKD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 33 / 79 / 49 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 32 / 9 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +31.8% |
| Market cap (USD) | $265.1M |